The impact of schedule on acute toxicity and dose-intensity of high-dose chemotherapy with epirubicin and cyclophosphamide plus colony stimulating factors in advanced breast cancer.

International journal of oncology

Volumn 15, Issue 2, 1999, Pages 339-346

  De Placido, S ^a   Lauria, R ^a   Carlomagno, C ^a   Perrone, F ^a   De Laurentiis, M ^a   Gallo, C ^a   Martignetti, A ^a   Bellelli, T ^a   Limite, G ^a   Petrella, G ^a   Bianco, A R ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; EPIRUBICIN; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;

AGED; ARTICLE; BREAST TUMOR; CANCER STAGING; CHEMICALLY INDUCED DISORDER; CLINICAL TRIAL; DOSE RESPONSE; DRUG ADMINISTRATION; FEASIBILITY STUDY; FEMALE; HEMATOLOGIC DISEASE; HUMAN; MORTALITY; PATHOLOGY; PHASE 1 CLINICAL TRIAL; SURVIVAL RATE; TREATMENT OUTCOME;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; CYCLOPHOSPHAMIDE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; EPIRUBICIN; FEASIBILITY STUDIES; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HEMATOLOGIC DISEASES; HUMANS; NEOPLASM STAGING; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 17744417701     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.15.2.339     Document Type: Article

References (0)